University of California, Los Angeles
University of California, Los Angeles
Los Angeles, California, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 3 | 2026-09-23 | NCT07252232 | |
| Colorectal Cancer Screening in Cystic Fibrosis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Infant, Newborn, Diseases, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, colonic disorder, colorectal cancer, colorectal neoplasm, cystic fibrosis, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, intestinal disorder, lung disorder, neoplasm, pancreas disorder, rectal disorder, respiratory system disorder | Active, not recruiting | Not stated | 2026-03-24 | NCT05362344 |